UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 349

Sortiert nach

Efficacy of Sequential Ipilimumab Monotherapy versus Best Supportive Care for Unresectable Locally Advanced/Metastatic Gastric or Gastroesophageal Junction Cancer

Clinical cancer research, 2017-10, Vol.23 (19), p.5671-5678

2017

Volltextzugriff (PDF)

Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial

The Lancet (British edition), 2012-01, Vol.379 (9813), p.315-321

2012

Volltextzugriff (PDF)

A phase I/II study of poziotinib combined with paclitaxel and trastuzumab in patients with HER2-positive advanced gastric cancer

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2019-11, Vol.22 (6), p.1206-1214

2019

Volltextzugriff (PDF)

Identification of different gene expressions between diffuse- and intestinal-type spheroid-forming gastric cancer cells

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2019-09, Vol.22 (5), p.967-979

2019

Volltextzugriff (PDF)

Health-related quality of life associated with regorafenib treatment in refractory advanced gastric adenocarcinoma

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2018-05, Vol.21 (3), p.473-480

2018

Volltextzugriff (PDF)

Efficacy and tolerability of ramucirumab monotherapy or in combination with paclitaxel in gastric cancer patients from the Expanded Access Program Cohort by the Korean Cancer Study Group (KCSG)

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2018-09, Vol.21 (5), p.819-830

2018

Volltextzugriff (PDF)

Randomized phase II study of capecitabine plus cisplatin with or without sorafenib in patients with metastatic gastric cancer (STARGATE)

Cancer medicine (Malden, MA), 2023-04, Vol.12 (7), p.7784-7794

2023

Volltextzugriff (PDF)

Everolimus for Previously Treated Advanced Gastric Cancer: Results of the Randomized, Double-Blind, Phase III GRANITE-1 Study

Journal of clinical oncology, 2013-11, Vol.31 (31), p.3935-3943

2013

Volltextzugriff (PDF)

Identification of potential lung cancer biomarkers using an in vitro carcinogenesis model

Experimental and Molecular Medicine, 2008, 40(6), , pp.709-720

2008

Volltextzugriff (PDF)

Isolation of spheroid-forming single cells from gastric cancer cell lines: enrichment of cancer stem-like cells

BioTechniques, 2018-10, Vol.65 (4), p.197-203

2018

Volltextzugriff (PDF)

A Selective FGFR inhibitor AZD4547 suppresses RANKL/M-CSF/OPG-dependent ostoclastogenesis and breast cancer growth in the metastatic bone microenvironment

Scientific reports, 2019-06, Vol.9 (1), p.8726-12, Article 8726

2019

Volltextzugriff (PDF)

Phase Ib and pharmacokinetics study of alpelisib, a PIK3CA inhibitor, and capecitabine in patients with advanced solid tumors

Frontiers in oncology, 2024-07, Vol.14, p.1390452

2024

Volltextzugriff (PDF)

Blood transfusion has an adverse impact on the prognosis of patients receiving chemotherapy for advanced colorectal cancer: experience from a single institution with a patient blood management program

Supportive care in cancer, 2022-06, Vol.30 (6), p.5289-5297

2022

Volltextzugriff (PDF)

The C-terminal region of Bfl-1 sensitizes non-small cell lung cancer to gemcitabine-induced apoptosis by suppressing NF-κB activity and down-regulating Bfl-1

Molecular cancer, 2011-08, Vol.10 (1), p.98-98

2011

Volltextzugriff (PDF)

Tumor-infiltrating Lymphocytes, Tumor Characteristics, and Recurrence in Patients With Early Breast Cancer

American journal of clinical oncology, 2013-06, Vol.36 (3), p.224-231

2013

Volltextzugriff (PDF)

Randomized phase II trial of nimotuzumab plus irinotecan versus irinotecan alone as second-line therapy for patients with advanced gastric cancer

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2015-10, Vol.18 (4), p.824-832

2015

Volltextzugriff (PDF)

Genomic Landscape and Clinical Utility in Korean Advanced Pan-Cancer Patients from Prospective Clinical Sequencing: K-MASTER Program

Cancer discovery, 2022-04, Vol.12 (4), p.938-948

2022

Volltextzugriff (PDF)

Tumor Suppressor miR-584-5p Inhibits Migration and Invasion in Smoking Related Non-Small Cell Lung Cancer Cells by Targeting YKT6

Cancers, 2021-03, Vol.13 (5), p.1159

2021

Volltextzugriff (PDF)

A phase 2 study of spartalizumab (PDR001) among patients with recurrent or metastatic esophageal squamous cell carcinoma (KCSG HN18-17, K-MASTER project 12)

Oncoimmunology, 2024-12, Vol.13 (1), p.2371563

2024

Volltextzugriff (PDF)

Gefitinib Versus Pemetrexed as Second-Line Treatment in Patients With Nonsmall Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy (KCSG-LU08-01): An Open-Label, Phase 3 Trial

Cancer, 2012-12, Vol.118 (24), p.6234-6242

2012

Volltextzugriff (PDF)

Effect of BRCA1 Haplotype on Survival of Non–Small-Cell Lung Cancer Patients Treated With Platinum-Based Chemotherapy

Journal of clinical oncology, 2008-12, Vol.26 (36), p.5972-5979

2008

Volltextzugriff (PDF)

Clathrin‐mediated EGFR endocytosis as a potential therapeutic strategy for overcoming primary resistance of EGFR TKI in wild‐type EGFR non‐small cell lung cancer

Cancer medicine (Malden, MA), 2021-01, Vol.10 (1), p.372-385

2021

Volltextzugriff (PDF)

A non-randomized, open-label, single-arm, Phase 2 study of emibetuzumab in Asian patients with MET diagnostic positive, advanced gastric cancer

Cancer chemotherapy and pharmacology, 2017-12, Vol.80 (6), p.1197-1207

2017

Volltextzugriff (PDF)

Identification of Biomarkers Associated with Liver Metastasis Progression from Colorectal Cancer Using Exosomal RNA Profiling

Cancers, 2022-09, Vol.14 (19), p.4723

2022

Volltextzugriff (PDF)

1 – 25 von 349

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(331)
Mit Volltextzugriff
(342)

Publikationsform

Artikel
(347)
Berichte
(2)

Sprache

Englisch
(327)
Japanisch
(26)
Koreanisch
(22)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(211)
Life Sciences & Biomedicine
(205)
Humans
(172)
Oncology
(150)
Female
(124)
Male
(108)
Middle Aged
(100)
Aged
(99)
Adult
(82)
Biological And Medical Sciences
(57)
Medical Sciences
(57)
Tumors
(53)
Chemotherapy
(45)
Medicine
(42)
Original
(42)
Aged, 80 And Over
(38)
Medicine & Public Health
(38)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(37)
Lung Cancer
(33)
Cancer Research
(32)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Efficacy of Sequential Ipilimumab Monotherapy versus Best Supportive Care for Unresectable Locally Advanced/Metastatic Gastric or Gastroesophageal Junction Cancer

Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial

A phase I/II study of poziotinib combined with paclitaxel and trastuzumab in patients with HER2-positive advanced gastric cancer

Identification of different gene expressions between diffuse- and intestinal-type spheroid-forming gastric cancer cells

Health-related quality of life associated with regorafenib treatment in refractory advanced gastric adenocarcinoma

Efficacy and tolerability of ramucirumab monotherapy or in combination with paclitaxel in gastric cancer patients from the Expanded Access Program Cohort by the Korean Cancer Study Group (KCSG)

Randomized phase II study of capecitabine plus cisplatin with or without sorafenib in patients with metastatic gastric cancer (STARGATE)

Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22–05): a single-arm, phase 1b–2 trial

Everolimus for Previously Treated Advanced Gastric Cancer: Results of the Randomized, Double-Blind, Phase III GRANITE-1 Study

Identification of potential lung cancer biomarkers using an in vitro carcinogenesis model

Isolation of spheroid-forming single cells from gastric cancer cell lines: enrichment of cancer stem-like cells

A Selective FGFR inhibitor AZD4547 suppresses RANKL/M-CSF/OPG-dependent ostoclastogenesis and breast cancer growth in the metastatic bone microenvironment

Phase Ib and pharmacokinetics study of alpelisib, a PIK3CA inhibitor, and capecitabine in patients with advanced solid tumors

Blood transfusion has an adverse impact on the prognosis of patients receiving chemotherapy for advanced colorectal cancer: experience from a single institution with a patient blood management program

The C-terminal region of Bfl-1 sensitizes non-small cell lung cancer to gemcitabine-induced apoptosis by suppressing NF-κB activity and down-regulating Bfl-1

Tumor-infiltrating Lymphocytes, Tumor Characteristics, and Recurrence in Patients With Early Breast Cancer

Randomized phase II trial of nimotuzumab plus irinotecan versus irinotecan alone as second-line therapy for patients with advanced gastric cancer

Genomic Landscape and Clinical Utility in Korean Advanced Pan-Cancer Patients from Prospective Clinical Sequencing: K-MASTER Program

Tumor Suppressor miR-584-5p Inhibits Migration and Invasion in Smoking Related Non-Small Cell Lung Cancer Cells by Targeting YKT6

A phase 2 study of spartalizumab (PDR001) among patients with recurrent or metastatic esophageal squamous cell carcinoma (KCSG HN18-17, K-MASTER project 12)

Gefitinib Versus Pemetrexed as Second-Line Treatment in Patients With Nonsmall Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy (KCSG-LU08-01): An Open-Label, Phase 3 Trial

Effect of BRCA1 Haplotype on Survival of Non–Small-Cell Lung Cancer Patients Treated With Platinum-Based Chemotherapy

Clathrin‐mediated EGFR endocytosis as a potential therapeutic strategy for overcoming primary resistance of EGFR TKI in wild‐type EGFR non‐small cell lung cancer

A non-randomized, open-label, single-arm, Phase 2 study of emibetuzumab in Asian patients with MET diagnostic positive, advanced gastric cancer

Identification of Biomarkers Associated with Liver Metastasis Progression from Colorectal Cancer Using Exosomal RNA Profiling

Suchergebnisse filtern